Biotech News

Click Here to Get the FREE MAGAZINE

Biotech News | 21.06.2020

There are lots of great articles about the best biotech stocks to buy now in the free monthly...

Biotech News Radius Health

Is Radius Health Stock a Good Buy Now?

Biotech News | 02.06.2020

The American biopharmaceutical company Radius Health is based out of Waltham (MA). Radius is...

Aveo Oncology Biotech News

Important Week Ahead for the Aveo Oncology Stock: +/- 400% on Friday?

Biotech News | 24.05.2020

This week is of critical importance for Aveo Oncology. The American company will present the final...

Biotech Clovis Oncology News

Clovis Oncology: One of the Top Biotech Takeover Targets for a Merger and Acquisition in 2020 or 2021

Biotech News | 20.05.2020

Major merger and acquisition activities can be expected for the biotech industry for the rest of...

Biotech News

Biotech Mergers and Acquisitions: Top Takeover Targets for 2020 – News, Rumors, What Is Next?

Biotech News | 17.05.2020

Mergers and acquisitions in biotech industry often result in a big fat premium for stock owners. In...

Biotech Intra-Cellular Therapies News

Biotech Hot Stock Intra-Cellular Therapies: The Next Takeover Target and Buyout Candidate for 2020?

Biotech News | 11.05.2020

Biotech experts are used to the never-ending merger and aquisition rumors in the news. Most of them...

Biotech News

Top Biotech Takeover Targets for 2020: Are These The Best Stocks to Buy Now?

Biotech News | 05.05.2020

More than 25 merger and acquisitions have been executed in the biotech sector in 2019. The volume...

Aveo Oncology Biotech News

Top Stock Speculative: Aveo Oncology, +25% Today!

Biotech News | 30.04.2020

Aveo Oncology’s stock shows a massive buy signal after the company has announced that the final...

Biotech Capricor Therapeutics News

Stock Alert: Why Does Capricor Therapeutics’ Share Jump 252% Today?

Biotech News | 29.04.2020

Shares of the California-based biotech Capricor Therapeutics skyrocket by more than 252% on...

Biotech Idorisa Pharmaceuticals News Portfolio

Idorsia Stock Explodes After Insomnia Drug Hits Primary Endpoint in Phase 3 Trial

Biotech News | 21.04.2020

Shares of the Swiss biotech Idorisa increase by more than 13% after the company has announced that...

Healthcare Politics News Science and Medicine

FDA Approves First Serological Antibody Test for SARS-CoV-2

Biotech News | 05.04.2020

The FDA grants the first emergency authorization for an antibody test against SARS-CoV-2. The test...

News Science and Medicine

Alzheimer’s Disease: Definition, Symptoms, Biomarkers, Research and Treatments

Biotech News | 04.04.2020

This article gives you a deep dive into Alzheimer's Disease including future...

Healthcare Politics News

COVID-19: Why Is Japan More Successful in Keeping the Numbers Low?

Biotech News | 02.04.2020

Although Japan was one of the first countries worldwide being reached by the current pandemic, no...

Healthcare Politics News

How Countries Ignore Drug Patents During the Coronavirus Pandemic to Save Lifes

Biotech News | 29.03.2020

Many countries’ emergency legislation on the coronavirus crisis provides them with powers to...

Biotech News Vir Biotechnology

Vir Biotechnology Identifies Two Antibodies with Therapeutic Potential for COVID-19

Biotech News | 25.03.2020

The US biotech Vir Biotechnology announced it will proceed with two antibodies with the potential...

News Pharma Roche

Roche: New Hope in the Fight Against the Coronavirus

Biotech News | 23.03.2020

The US Food and Drug Administration (FDA) allows the Swiss pharmaceutical company Roche to test its...

Healthcare Politics News Science and Medicine

FDA Guidance: Performing Clinical Trials in Times of Coronavirus Pandemic

Biotech News | 19.03.2020

One of the biggest concerns of pharmaceutical and biotech companies as well as from trial sites...

Healthcare Politics News

The Cost of China’s Public Health Cover-Up: Will China Be Punished by the World?

Biotech News | 15.03.2020

After SARS in 2002 and the new Coronavirus, China was the origin of the last two major health...

Diagnostics News Pharma Roche

Coronavirus: Why Roche’s Diagnostic Test Is a Real Game Changer

Biotech News | 14.03.2020

The Swiss pharmaceutical company Roche developed a new diagnostic test for SARS-CoV-2 which...

Biotech News Novavax What's up

This Is the Reason Why Novavax’ Stock Is Skyrocketing: +6.3% Today!

Biotech News | 10.03.2020

In addition to suppliers of medical equipment such as respiratory masks or other protective...

Healthcare Politics News Science and Medicine

Coronavirus Treatment and Vaccine: Most Promising Candidates, Mechanism of Action, Timelines

Biotech News | 08.03.2020

Researchers are testing drugs against the new Coronavirus in clinical trials and several vaccine...

Alnylam Pharmaceuticals Biotech News Portfolio Vir Biotechnology

Alnylam and Vir Expand Collaboration to Develop RNAi Therapeutics for Coronavirus Infection

Biotech News | 06.03.2020

Alnylam Pharmaceuticals and Vir Biotechnology expand their collaboration to advance siRNA...

News Pharma Roche

Roche’s Esbriet Gets FDA Breakthrough Designation for Interstitial Lung Disease

Biotech News | 03.03.2020

Genentech, a member of the Roche Group, today announced that the FDA has granted Breakthrough...

Biotech News Portfolio Sangamo Therapeutics

Sangamo Therapeutics: $2.7 Billion Deal with Biogen for Neurodegenerative Disorders

Biotech News | 02.03.2020

Sangamo Therapeutics and Biogen announced a global licensing collaboration deal for the development...

Healthcare Politics News Science and Medicine

Q & A on the Coronavirus: Virulence, Mortality, Impact on Economy and Markets, Outlook

Biotech News | 27.02.2020

According to the lastest update of the World Health Organization (WHO), the Coronavirus outbreak...

Healthcare Politics News Science and Medicine

Can Respiratory Masks Really Stop Virus? Here Are the Scientific Facts

Biotech News | 25.02.2020

In the epidemic regions in China, Italy, South Korea and Iran, many cities have been locked down....

Biotech Esperion Therapeutics News Portfolio

FDA Approves Esperion’s Cholesterol-Lowering Drug Nexletol

Biotech News | 25.02.2020

The US Food and Drug Administration approves Esperion’s oral LDL-Cholesterol (LDL-C) lowering...

AB Science Biotech News

AB Science With Positive Trial in Progressive Forms of Multiple Sclerosis

Biotech News | 23.02.2020

Last Thursday, AB Science announced positive top-line results of a phase 2B/3 trial for oral...

Healthcare Politics News Science and Medicine

Coronavirus Outbreak: Italy Puts 10 Towns on Lockdown

Biotech News | 23.02.2020

After two deaths and 132 confirmed cases of infections, the Italian government has decided to take...

Biotech Incyte News Portfolio

Incyte With Second Positive Pivotal Trial in Atopic Dermatitis (Eczema)

Biotech News | 19.02.2020

Incyte today announced that also the second of two identical phase 3 trials with Ruxolitinib cream...

Healthcare Politics News Science and Medicine

What Genetics Tells Us About the Outbreak and Origin of the Virus

Biotech News | 18.02.2020

Between mid-November and early December, the Coronavirus SARS-CoV-2 must have made the transmission...

Biotech Esperion Therapeutics News

Esperion Therapeutics: Important Days Ahead!

Biotech News | 18.02.2020

The next two weeks are of critical importance for the US pharmaceutical company Esperion...

Healthcare Politics News Science and Medicine

More Than 90 Clinical Trials in China for New Coronavirus Treatment

Biotech News | 16.02.2020

The number of infections and deaths caused by the novel Coronavirus, officially referred to as...

Healthcare Politics News Science and Medicine

Coronavirus: Are ‘Experts’ and Stock Markets Much Too Optimistic?

Biotech News | 13.02.2020

China reported an enormous increase in new Coronavirus infections within just one day. The number...

Healthcare Politics News Science and Medicine

NEJM Article Suggests SARS-CoV-2 Originates From Seafood Wholesale Market in Wuhan

Biotech News | 13.02.2020

Researchers from the Chinese Centers for Disease Control and Prevention in Beijing and Wuhan...

Healthcare Politics News Science and Medicine

Novel Coronavirus Has an Official Name: SARS-CoV-2

Biotech News | 11.02.2020

The WHO has called on the world to act as aggressively as possible against the novel Coronavirus....

Biotech Eli Lilly News Roche

Severe Setback on the Way Towards a Therapy for Alzheimer’s Disease

Biotech News | 11.02.2020

Roche and Eli Lilly announced that their anti-amyloid beta antibodies failed a phase 2/3 clinical...

Healthcare Politics News Science and Medicine

Coronavirus Can Survive on Surfaces for up to 9 Days

Biotech News | 09.02.2020

According to a report of German researchers, Coronaviruses are capable of surviving on surfaces and...

Biotech GW Pharmaceuticals News Portfolio

GW Pharmaceuticals Jumps 7%: Is Now the Time to Buy this Stock?

Biotech News | 08.02.2020

Shares of GW Pharmaceuticals, a global leader in cannabinoid-based medicines and member of our...

Healthcare Politics News Science and Medicine

60 Million Chinese People Under Quarantine: Can this Measure Halt the Spread of the Virus?

Biotech News | 06.02.2020

As a measure to control the spread of the novel Coronavirus, more than 60 million people in China...

Healthcare Politics News Science and Medicine

Switzerland: Chocolate? Cheese? Watches? It’s the Global Pharmacy!

Biotech News | 04.02.2020

Switzerland is known worldwide for chocolate, cheese, watches, and banks. The country's image,...

Aimmune Therapeutics Biotech News

FDA Approves First Treatment for Peanut Allergy

Biotech News | 03.02.2020

Good news for millions of people worldwide suffering from an allergy to peanuts. The FDA approves...

Healthcare Politics News Science and Medicine

Where Does the Name Coronavirus Come From?

Biotech News | 29.01.2020

Based on the last google search queries, many people seem to wonder whether there is a correlation...

Biotech Incyte News Portfolio

Incyte With Second Positive Phase 3 Trial in Atopic Dermatitis Within Two Days

Biotech News | 28.01.2020

These are truly exciting days for Incyte. The American biopharmaceutical company and member of our...

Healthcare Politics News Science and Medicine

Coronavirus Outbreak: How Virulent Is 2019-nCoV?

Biotech News | 27.01.2020

The measures of the Chinese government could hardly be more drastic: More than 45 million people in...

Biotech Eli Lilly Incyte News Portfolio

Eli Lilly and Incyte’s Olumiant Clears Pivotal Trial in Atopic Dermatitis

Biotech News | 27.01.2020

Incyte and Eli Lilly today announced the results from a phase 3 clinical trial with Olumiant...

Healthcare Politics News Science and Medicine

China’s Research Lab to Study SARS and Ebola Is Located in Wuhan: Does the Coronavirus Really Come From Wuhan’s Animal Market?

Biotech News | 26.01.2020

According to the latest state of knowledge, an animal market in Wuhan is the source of the current...

Biotech Myovant Sciences News

Myovant Sciences: One of the Takeover Targets in Biotech Industry for 2020

Biotech News | 24.01.2020

More than 25 mergers and acquisitions have been executed in biotech industry in 2019. It is...

Healthcare Politics News Science and Medicine

How Does the Coronavirus Impact Global Economy and Stock Markets?

Biotech News | 22.01.2020

The number of infections and deaths caused by the newly discovered coronavirus is strongly...

Biotech Hutchinson China Meditech News Portfolio

Hutchison China Meditech Stops Phase 3 Trial in Pancreatic Cancer Upon Early Success

Biotech News | 21.01.2020

Hutchison China Meditech, also known as Chi-Med, has terminated a phase 3 clinical trial with...

Biotech Lonza News Portfolio

Lonza Group’s Share Jumps: Higher Profit and Focus on Biotech

Biotech News | 21.01.2020

The Swiss Lonza Group, a leading supplier to the pharmaceutical and biotech industry and member of...

Biotech Evotec News Portfolio

Evotec Exceeds Expectations: The Specialist for Biologics Is on Track

Biotech News | 20.01.2020

Thanks to good business in the fourth quarter and unexpectedly high milestone payments, the...

Healthcare Politics News Science and Medicine

Fear of a New Coronavirus From Wuhan, China, Is Growing: Symptoms, Treatment and Vaccines

Biotech News | 19.01.2020

Health authorities in Wuhan, central China, yesterday confirmed four new infections with a new...

Biotech Clovis Oncology News

Clovis Oncology: One of the Takeover Targets in Biotech Industry for 2020

Biotech News | 17.01.2020

The biotech industry is well-known for its merger and acquisition activities and a lot of takeover...

News Science and Medicine

Gene Therapy: Definition, Examples, Pros and Cons, and News

Biotech News | 16.01.2020

Although gene therapy belongs to the hot topics of modern medicine, most people do not a lot about...

Astellas Audentes Therapeutics Biotech News

Astellas Pharma Completes Acquisition of Audentes Therapeutics

Biotech News | 15.01.2020

Astellas Pharma today announced that it has successfully completed the planned acquisition of...

Biotech Deciphera Pharmaceuticals News

One of the Top Biotech Takeover Targets for 2020: Deciphera Pharmaceuticals

Biotech News | 15.01.2020

Major merger and acquisition activities in the biotech industry can most likely also be expected...

Biotech News Portfolio

Biotech Investments Model Portfolio: +26.1% in 2019!

Biotech News | 31.12.2019

The year 2019 was once again a very successful one. The performance of the Biotech Investments...

Biotech News Qiagen

Qiagen Stock Crashes: Company Rebuffs all Takeover Offers

Biotech News | 28.12.2019

Qiagen decided to stay alone After multiple takeover offers over the past few months, the company...

Biotech Intercept Pharmaceuticals News

Is 2020 Going to Be the Year for the First Approved Treatment for the Fatty Liver Disease NASH?

Biotech News | 22.12.2019

Nonalcoholic steatohepatitis (NASH) is a modern lifestyle condition which is mainly driven by...

Biogen Biotech Ionis Pharmaceuticals News

Biogen Continues to Search for a Breakthrough in Alzheimer’s: 45 Million for Ionis’ Phase 1 Drug

Biotech News | 19.12.2019

Biogen hasn’t resigned yet in the search for a major breakthrough in Alzheimer’s disease. The...

Biotech Macrogenics News Portfolio

Macrogenics Submits Biologics License Application for Margetuximab to FDA

Biotech News | 19.12.2019

Macrogenics, the US oncology company and member of our Biotech Investments Model Portfolio, today...

Agios Pharmaceuticals Biotech News Portfolio

Agios Pharmaceuticals: FDA Breakthrough Therapy Designation for Tibsovo in Myelodysplastic Syndrome

Biotech News | 18.12.2019

Agios Pharmaceuticals’ cancer drug Tibsovo is granted FDA breakthrough therapy designation for...

Alnylam Pharmaceuticals Biotech News Portfolio

Alnylam Reports Positive Phase 3 Results for its ILLUMINATE-A Trial of Lumasiran in Primary Hyperoxaluria

Biotech News | 17.12.2019

The US biotech company and specialist in RNA interference therapies Alnylam Pharmaceuticals today...

Biotech News Portfolio Sarepta Therapeutics

Sarepta: Share Price Explosion after FDA Hammer! And now?

Biotech News | 15.12.2019

There is only one suitable word for yesterdays’ news: sensation! The American healthcare...

Audentes Therapeutics Biotech News Portfolio

Astellas Pharma to Buy Audentes for $3 Billion: +270 since January 2019%!

Biotech News | 02.12.2019

We have to say goodbye to our Biotech Investments Model Portfolio member Audentes Therapeutics. The...

Biotech News Portfolio

Biotech Investments Model Portfolio: +23.1% as of November 30!

Biotech News | 01.12.2019

Biotech Investments' Model Portfolio performance is +23.1% as of November 30. This corresponds to...

Biotech Corbus Pharmaceuticals News Portfolio

Corbus Pharmaceuticals Presents Phase 2 OLE Data for Lenabasum: Is This Stock a Buy Now?

Biotech News | 11.11.2019

Corbus Pharmaceuticals today presented the open-label-extension (OLE) data from its two phase 2...

Biotech News Portfolio Science and Medicine Vertex Pharmaceuticals

Vertex Pharmaceuticals and Trikafta: Hope for Patients With Cystic Fibrosis

Biotech News | 10.11.2019

  The US Food and Drug Administration FDA has approved a drug against cystic fibrosis that...

News

Our Ask: Your Honest Feedback!

Biotech News | 10.11.2019

  Dear Readers It has been exactly one year since we started with Biotech Investments....

Biotech Evotec News Vifor Pharmaceuticals

Evotec and Vifor Pharmaceuticals with Joint Venture for New Nephrology Drugs

Biotech News | 10.11.2019

Evotec and Vifor Pharmaceuticals today announced a joint venture for the development of drugs for...

Biotech Incyte News Portfolio

Incyte Opts for Switzerland as its New European Headquarters

Biotech News | 10.11.2019

The American biotech company Incyte has chosen the Swiss city Morges as its European headquarters....

Biotech Esperion Therapeutics News Portfolio

Esperion Therapeutics to Present Pooled Analyses from its Phase 3 Trials with Bempedoic Acid at AHA Congress

Biotech News | 04.11.2019

Esperion Therapeutics today announced that it will present a pooled analysis of its 4 phase 3...

Centogene Diagnostics News

Evotec Partner Centogene Plans IPO: Is It a Good Deal for Investors?

Biotech News | 04.11.2019

Not even one month after BioNTech’s IPO in New York, there is already another promising German...

Healthcare Politics News

It’s Official: Donald Trump Picks Stephen Hahn as New FDA Commissioner

Biotech News | 03.11.2019

As we have already speculated in earlier reports, US President Donald Trump has nominated Stephen...

Amgen BeiGene Biotech News Portfolio

Hammer Deal: Amgen Joins Model Portfolio Member BeiGene – Share Explodes 37 Percent!

Biotech News | 01.11.2019

The biotech giant Amgen wants to increase its presence in China. The Americans will buy 20.5% of...

Biotech News Portfolio

Biotech Investments Model Portfolio: +4.1% as of October 31

Biotech News | 31.10.2019

Biotech Investments' Model Portfolio performance is +4.1% as of October 31. This corresponds to an...

Healthcare Politics News

Switzerland Accuses 11 Pharmaceutical Companies for Illegal Price Agreements

Biotech News | 31.10.2019

The Swiss Competition Commission Weko is investigating eleven pharmaceutical suppliers worldwide....

Dicerna Pharmaceuticals News Pharma Roche

Roche to Pay $200 Million for Rights to RNAi Hepatitis B Drug

Biotech News | 31.10.2019

The Basel-based Swiss pharmaceutical company Roche is spending $200 million for a global licensing...

Biotech CRISPR Therapeutics News Portfolio Vertex Pharmaceuticals

Takeover Rumors about CRISPR Therapeutics: Does Vertex Make a Move?

Biotech News | 30.10.2019

As a result of new takeover rumors, CRISPR Therapeutics’ share price has increased more than 27%...

Biotech Macrogenics News Portfolio

Pfizer Stops Collaboration with Macrogenics on a Bispecific Antibody for Solid Tumors

Biotech News | 29.10.2019

Macrogenics has to digest a severe setback as Pfizer plans to stop a collaboration on a bispecific...

Biotech Morphosys News

Morphosys, Galapagos and Novartis to Shut Down Atopic Dermatitis Program

Biotech News | 29.10.2019

Morphosys, Galapagos, and Novartis have to accept a severe setback with their clinical trial...

News Science and Medicine

Gene and Cell Therapies: What Does the Future Hold?

Biotech News | 28.10.2019

Following a general introduction to the topic, our series of articles on gene and cell therapies...

News Science and Medicine

Prime Editing: Sharper Gene Scissors for Better Gene Therapies

Biotech News | 27.10.2019

US researchers are developing a method that could enable better gene therapies for a big number of...

Healthcare Politics News

Is Big Pharma Facing Another Problem? NIH and Gates Foundation Commit $200 Million for Cheaper Gene Therapies

Biotech News | 25.10.2019

The National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation have committed...

News Pharma Roche

A Glimmer of Hope for Roche in the Battle for Spark Takeover

Biotech News | 25.10.2019

The employees of the US antitrust authority FTC approve the planned takeover of Spark Therapeutics....

Biotech News Polyphor

Polyphor Identifies New Class of Antibiotics: Stock Explodes!

Biotech News | 24.10.2019

Researchers from the Swiss biotech company Polyphor and the University of Zurich have presented the...

Healthcare Politics News

WSJ: President Trump Wants to Have Stephen Hahn as New FDA Commissioner

Biotech News | 24.10.2019

According to a report of the Wall Street Journal US President Donald Trump is planning to pick MD...

BioNTech Biotech News

BioNTech: Is This Stock a Buy Now?

Biotech News | 23.10.2019

The stock of BioNTech has gone through a real rally since its IPO on October 10. From Tuesday,...

Biotech Macrogenics News Portfolio

Macrogenics Stocks Down 15% after Presentation of Updated Survival Data for Margetuximab

Biotech News | 23.10.2019

Shares of the Biotech Investments Model Portfolio member Macrogenics are down 15% to $9.38 today...

Biotech News Seattle Genetics

Seattle Genetics Stock Jumps after Positive Trial Results with ErbB-2 Inhibitor Tucatinib

Biotech News | 22.10.2019

Seattle Genetics was one of the main winners of this year's ESMO congress. The company's shares...

News Science and Medicine

Cell Therapies: Mechanism of Action and Successful Examples

Biotech News | 21.10.2019

Thanks to the major progress made in the field of gene and cell therapies, a new age has finally...

News Science and Medicine

Pennsylvania’s Kymriah Pioneers with another Breakthrough

Biotech News | 20.10.2019

Chimeric antigen receptor T cells (CAR-T) have been demonstrated to be an outstanding treatment...

Alexion Pharmaceuticals Biotech News Portfolio

FDA Approves Alexion’s Ravulizumab for Atypical Hemolytic Uremic Syndrome

Biotech News | 19.10.2019

The US healthcare authority FDA on Friday approved Alexion Pharmaceuticals’ drug Ravulizumab for...

News Pharma Roche

Roche with Strong Growth and Third Full-Year Guidance Increase since January 2019

Biotech News | 17.10.2019

The pharmaceutical giant increased sales by ten percent in the first three quarters, more than...

Alexion Pharmaceuticals Biotech News Portfolio

Alexion with $930 Million Takeover of Achillion Pharmaceuticals to Expand Drug Pipeline for Rare Immunological Diseases

Biotech News | 16.10.2019

The big merger and acquisition (M&A) wave in biotech industry continues. Alexion...

Biotech Incyte News Portfolio

Incyte’s Ruxolitinib Cream with Positive Phase 2 Trial in Vitiligo

Biotech News | 14.10.2019

A phase 2 clinical trial with Incyte’s Ruxolitinib cream in patients with vitiligo met its...

News Pharma UCB

UCB with $2.5 Billion Takeover of Rare Disease Specialist Ra Pharmaceuticals

Biotech News | 10.10.2019

The Belgian pharma giant UCB, a specialist for neurological and immunological disorders, announced...

Biotech Ionis Pharmaceuticals News Portfolio

Bayer Advances with Ionis’ Factor XI Anti-Thrombotic Drug

Biotech News | 09.10.2019

Ionis Pharmaceuticals, a leader in antisense therapy with a pipeline of more than 40 drug...

BioNTech Biotech News

BioNTech IPO: a Good Deal for Investors?

Biotech News | 09.10.2019

The German biotech company BioNTech is one of the hot players in the field of flu vaccine...

News Science and Medicine

Gene and Cell Therapies: an Introduction

Biotech News | 06.10.2019

A new age has finally begun for the treatment of many serious diseases. Thanks to the latest...

Healthcare Politics News

Stephen Hahn from MD Anderson’s as the Next Head of the FDA?

Biotech News | 03.10.2019

According to a report from BioCentury, US president Donald Trump favors Stephen Hahn, a radiation...

Biotech Deciphera Pharmaceuticals News

Deciphera Pharmaceuticals: One of the Top Takeover Targets in Biotech Industry?

Biotech News | 02.10.2019

Deciphera Pharmaceuticals, a Waltham (Massachusetts)-based specialist for precision oncology, is...

Biotech News Portfolio Sangamo Therapeutics

Sangamo Therapeutics Hires New Chief Medical Officer

Biotech News | 01.10.2019

Sangamo today announced Bettina Cockroft as a new chief medical offier for its gene editing...

Biotech News Portfolio Vertex Pharmaceuticals

Vertex Pharmaceuticals Appoints Carmen Bozic as New Chief Medical Officer

Biotech News | 01.10.2019

Vertex Pharmaceuticals' today announced Carmen Bozic as a successor of the previous chief medical...

Biotech Hutchinson China Meditech News Portfolio

CK Hutchison Offers 1.3% of Hutchison China Meditech’s Share Capital

Biotech News | 30.09.2019

Hutchison China Meditech Limited, also known as Chi-Med, today announced in London that its...

Agios Pharmaceuticals Biotech News Portfolio

Agios’ Drug Tibsovo Prolongs Progression-Free Survival in Phase 3 Cholangiocarcinoma Trial by only 2 Months, Shares Down by 6%

Biotech News | 30.09.2019

Agios Pharmaceuticals today announced the presentation of phase 3 clinical trial data for Tibsovo....

Biotech Macrogenics News Portfolio

Macrogenics Presents Updated Analysis of its Phase 2 Trial with Margetuximab in Metastatic Gastroesophageal Cancer: Share Gains more than 4%

Biotech News | 30.09.2019

Macrogenics, a US biotechnology company focusing on the development of novel antibody therapies for...

News Pharma Roche

Roche Extends Takeover Offer for Spark Therapeutics Again

Biotech News | 30.09.2019

Swiss pharma giant Roche is again extending its takeover offer for Spark Therapeutics. The offer...

Biotech News Portfolio

Biotech Investments Model Portfolio: +3.1% as of September 29

Biotech News | 29.09.2019

The Performance of Biotech Investments Model Portfolio is +3.1% as of September 29. After a...

News Pfizer Pharma

Pfizer’s JAK Inhibitor Abrocitinib Hits its Primary Endpoint in a Second Phase 3 Trial for Atopic Dermatitis

Biotech News | 27.09.2019

Pfizer’s drug Abrocitinib, an oral inhibitor of the Janus kinase 1 (JAK1), met its primary...

Biotech Incyte News Portfolio

Incyte with Positive Results from Phase 2 Trial of Pemigatinib in Advanced Cholangiocarcinoma

Biotech News | 27.09.2019

The US pharmaceutical company Incyte, a member of our Biotech Investments Model Portfolio which is...

Biotech Jazz Pharmaceuticals News

Jazz Pharmaceuticals Announces Positive Phase 3 Data for Narcolepsy

Biotech News | 26.09.2019

JZP-258, a novel oxybate product candiadate by Jazz Pharmaceutials, was successfully tested in a...

Biotech Incyte News Portfolio

Incyte Announces Successful Initiation of Phase 3 Program with Ruxolitinib Cream for Patients with Vitiligo

Biotech News | 25.09.2019

The US pharmaceutical company Incyte today released an announcement saying that the phase 3...

News Novartis Pharma

Novartis Accuses Avexis Ex-Employees of Data Manipulation in Development of Zolgensma

Biotech News | 25.09.2019

According to Novartis, two former high-ranking employees of the subsidiary Avexis are responsible...

News Pharma Roche

British Competition and Markets Authority CMA Wants an In-Depth Examination of Roche’s Takeover of Spark Therapeutics

Biotech News | 25.09.2019

The $4.3 billion takeover of the gene therapy specialist Spark Therapeutics by the Swiss pharma...

Biotech Evotec News

Evotec and Takeda Agree on a Deal for Drug Discovery

Biotech News | 24.09.2019

The Hamburg-based biotech company Evotec which offers services to partners such as Sanofi or Bayer...

Akcea Therapeutics Biotech News Portfolio

Akcea Therapeutics Appoints Damien McDevitt as Interim CEO

Biotech News | 23.09.2019

Akcea Therapeutics, a Cambridge-based affiliate of Ionis Pharmaceuticals specialized on the...

Healthcare Politics News

New Attempt by the US Government to Lower Drug Prices

Biotech News | 22.09.2019

Nancy Pelosi, speaker of the United States House of Representatives, said on Thursday that the...

News Novo Nordisk Pharma

Important Milestone for Novo Nordisk: FDA Approves Oral Version of its Type 2 Diabetes Drug Semaglutide (Rybelsus)

Biotech News | 21.09.2019

This are great news for the Danish diabetes specialist Novo Nordisk. The American healthcare...

Diagnostics News Roche

Roche with Continuous Positive News Flow: FDA Approval for Cobas Whole Blood Screening Test

Biotech News | 20.09.2019

The Swiss pharmaceutical company Roche has today announced that its Cobas platform has gained FDA...

Biotech Five Prime Therapeutics News

Five Prime Therapeutics CEO Aron Knickerbocker is Leaving the Company

Biotech News | 20.09.2019

Aron Knickerbocker, CEO of the San Francisco-based immune-oncology firm Five Prime Therapeutics, is...

News Novartis Pharma

Novartis Presents Interim Analysis of its Phase 3 trial of Zolgensma in Spinal Muscular Atrophy Type 1

Biotech News | 19.09.2019

The gene therapy player AveXis which was acquired by Novartis for $8.7 billion in 2018 today...

Biotech News Portfolio Vertex Pharmaceuticals

Quo Vadis, Vertex Pharmaceuticals?

Biotech News | 18.09.2019

The Boston-based US biopharmaceutical company Vertex Pharmaceuticals, specialized in the treatment...

Biotech News Zynerba Pharmaceuticals

Zynerba Pharmaceuticals Reports Positive Topline Data from a Phase 2 Study of its CBD Gel Treatment Zygel in Patients with Encephalopathies

Biotech News | 18.09.2019

Zynerba Pharmaceuticals, a small US company specialized on next-generation cannabinoid therapeutics...

News Novartis Pharma

Novartis Paves the Way Towards a Fourth Indication for Cosentyx: Positive Phase 3 Trial Data in Non-Radiographic Spondyloarthritis

Biotech News | 18.09.2019

The Swiss pharma giant Novartis today announced new data from its phase 3 clinical trial program...

Biotech CRISPR Therapeutics News Portfolio

CRISPR Therapeutics and ViaCyte Present Promising In-Vitro Data Towards a Potential Diabetes Cure

Biotech News | 17.09.2019

CRISPR Therapeutics, a company specialized on gene therapies for severe diseases using a...

Alnylam Pharmaceuticals Biotech News Portfolio

Alnylam Pharmaceuticals Initiates New Phase 3 Trial of Patisiran for the Treatment of Patients with Transthyretin Amyloidosis with Cardiomyopathy

Biotech News | 16.09.2019

Alnylam Therapeutics, a leading RNA interference company and member of our Biotech Investments...

Akcea Therapeutics Biotech News Portfolio

Akcea Therapeutics Presents Positive Phase 1 Results for its Transthyretin Amyloidosis Drug AKCEA-TTR-LRx

Biotech News | 16.09.2019

The Boston-based US biotechnology company Akcea Therapeutics today presented positive results of a...

Healthcare Politics News

Back to Square One: Netherlands’ Hard Setback in Their Fight for Affordable Drug Prices for Rare Diseases

Biotech News | 15.09.2019

Pharmacists in the European Union are only allowed to buy medicines for individual patients. In the...

News Novartis Pharma

Novartis Presents Phase 3 Data of its Clinical Trials ASCLEPIOS I and II with Arzerra (Ofatumumab) in Patients with Relapsing Multiple Sclerosis

Biotech News | 14.09.2019

Novartis makes major progress towards the anticipated approval for its multiple sclerosis (MS) drug...

Biotech News Portfolio

Alnylam Pharmaceuticals Adds an Additional Piece of Evidence to the Pathogenic Role of the V122I Mutation of Transthyretin

Biotech News | 13.09.2019

The Cambridge-based US biopharmaceutical company Alnylam Pharmaceuticals, a market leader in RNA...

News Pharma Roche

Roche’s IL6 Receptor Antagonist Satralizumab Reduces Relapse Risk in Neuromyelitis Optica Spectrum Disorder

Biotech News | 12.09.2019

Roche has today presented phase 3 clinical trial data on its IL-6 receptor antagonist satralizumab...

Janssen Pharmaceuticals News Pharma

Janssen Reports New Head-to-Head Phase 3 Study Data Demonstrating Ponesimod Superiority versus Aubagio (Teriflunomide) in Patients with Relapsing Multiple Sclerosis

Biotech News | 11.09.2019

Janssen today reported the data of its phase 3 study OPTIMUM at the 35th Congress of The European...

Biotech News Portfolio

BioSpace Article on the Top Takeover Targets: 4 out of 10 Companies Are Part of the Biotech Investments Model Portfolio

Biotech News | 11.09.2019

BioSpace, a mouthpiece for news from the biotech industry, today released an interesting article on...

Aveo Oncology Biotech News

AVEO Oncology Announces Updated Overall Survival Data of its Phase 3 TIVO-3 Trial of Tivozanib in Patients with Renal Cell Carcinoma, Stock Jumps by 40%

Biotech News | 10.09.2019

The Cambridge-based US biopharmaceutical company AVEO Oncology today announced the results from the...

BeiGene Biotech News Portfolio

BeiGene Has to Defend Against Short Report, Share Plunges

Biotech News | 10.09.2019

BeiGene, the outstanding example of the fast-developing Chinese biotech industry and member of the...

Biotech News Polyphor

Polyphor Share Price Jumps by 30% After CEO Statements

Biotech News | 09.09.2019

Shares of the Swiss biotech company Polyphor jump at the beginning of this week. Reason being the...

Biotech Edesa Biotech News

Edesa Shares Jump After Health Canada Approval to Begin Clinical Trial in Patients with Hemorrhoids

Biotech News | 06.09.2019

The stock of Edesa biotech jumps in response to Health Canada's decision to approve a clinical...

Biotech News Portfolio

Biotech Investments Model Portfolio: +14.8% as of August 31

Biotech News | 05.09.2019

The Performance of Biotech Investments Model Portfolio is +14.8% as of August 31. Although this...

Biotech News Portfolio Vertex Pharmaceuticals

Vertex Pharmaceuticals Pays $950 Million for Stem Cell Player Semma Therapeutics

Biotech News | 03.09.2019

Vertex Pharmaceuticals, the US cystic fibrosis specialist and member of our Biotech Investments...

Biotech Esperion Therapeutics News Portfolio

Esperion’s Cholesterol-Lowering Drug Bembedoic Acid With Positive Top-Line Results from Phase 2 Trial in Patients with Type 2 Diabetes

Biotech News | 29.08.2019

Esperion Therapeutics, a US-based pharmaceutical company specialized in the development of oral...

Biotech Kezar Life Sciences News Portfolio

Kezar Life Sciences Share still under Strong Pressure

Biotech News | 27.08.2019

Kezar Life Sciences is currently still in a difficult position on the stock exchange. The...

Alexion Pharmaceuticals Biotech News Portfolio

Takeover Rumors Boost Alexion Pharmaceuticals Share

Biotech News | 23.08.2019

The share price of our sample portfolio member Alexion Pharmaceuticals exploded this week. The...

Biotech News Portfolio Sarepta Therapeutics

Sarepta Therapeutics: FDA Refuses Marketing Approval for Duchenne Drug Golodirsen

Biotech News | 19.08.2019

The gene therapy powerhouse Sarapta Therapeutics and member of our Model Portfolio has to digest...

Biotech News Roche

Roche Receives FDA Approval for Cancer Drug Rozlytrek

Biotech News | 16.08.2019

Roche, the Basel-based pharmaceutical company, announced this morning that it has received approval...

Biotech Evotec News

Evotec Publishes Convincing Half-Yearly Results, Share Plunges

Biotech News | 15.08.2019

Despite the announcement of convincing half-year results and an increase in the forecast for 2019...

Biotech News Santhera Pharmaceuticals

Santhera CFO Christoph Rentsch Leaves the Company, Share Loses More than 6%

Biotech News | 15.08.2019

Santhera today announced in a press release that there has been a change in management. CFO...

Biotech News Portfolio Sarepta Therapeutics

Sarepta after Drop in Share Price: CEO Ingram Now Buys on a Grand Scale

Biotech News | 13.08.2019

After a patient developed a severe side effect in a gene therapy study, the Sarepta share price...

Biotech News Portfolio Sarepta Therapeutics

Sarepta Comments on Incorrect Submission to FDA’s FEARS Adverse Events Reporting System

Biotech News | 08.08.2019

Sarepta Therapeutics, a leading provider of gene therapy for rare diseases and a member of our...

Audentes Therapeutics Biotech News Portfolio

Audentes Therapeutics Publishes Business and Pipeline Update for Second Quarter 2019

Biotech News | 06.08.2019

Audentes Therapeutics, a member of our Model Portfolio specializing in the development of gene...

Agios Pharmaceuticals Biotech News Portfolio

Encouraging Second Quarter for Agios Pharmaceuticals: IDH inhibitor Tibsovo Shows Strong Growth

Biotech News | 01.08.2019

Agios Pharmaceuticals, a company specializing in the development of oncology and rare genetic...

Biotech News Portfolio Vertex Pharmaceuticals

Vertex Pharmaceuticals Increases Sales by 25% in the Second Quarter of 2019

Biotech News | 01.08.2019

Vertex Pharmaceuticals yesterday evening announced its financial results for the second quarter of...

Biotech Macrogenics News Portfolio

Macrogenics Publishes Business and Pipeline Update for the Second Quarter of 2019, Share Price Falls Slightly

Biotech News | 31.07.2019

Our Model Portfolio member Macrogenics, which specializes in the development of innovative antibody...

Biotech Incyte News Portfolio

Model Portfolio Member Incyte Increases Turnover in the Second Quarter, Share Price Rises 6%

Biotech News | 30.07.2019

Our sample portfolio value Incyte today presented its annual report for the second quarter of 2019...

Diagnostics News Siemens Healthineers

Siemens Healthineers Increases Net Income by 20% in the Third Quarter: Share Price Increases by More than 5%

Biotech News | 29.07.2019

Siemens Healthineers increased sales to €3.6 billion in the third quarter. Adjusted for currency...

Biotech News Portfolio

Biotech Investments Model Portfolio: +26.7% as of 28 July 2019

Biotech News | 28.07.2019

The Model Portfolio of Biotech Investments developed extremely positively in the first seven months...

Johnson & Johnson News Pharma

Johnson & Johnson’s Multiple Sclerosis Drug Ponesimod Hits Sanofi Drug Aubagio in Phase 3 Trial

Biotech News | 27.07.2019

Johnson & Johnson announced that it has successfully completed its Phase 3 study program with...

News Novartis Pharma

Novartis Holds on to Sandoz Generics Subsidiary

Biotech News | 27.07.2019

Novartis CEO ends speculation about sale of Sandoz and Hexal Genrika divisions. The aim is to make...

Biotech News Solid Biosciences

Solid Biosciences Share Rises by more than 30%!

Biotech News | 26.07.2019

Solid Biosciences' share price today rose by over 30%. This is due to a private placement of 10.6...

News Pharma Roche

Roche Raises Outlook and Dividend: Share Gains

Biotech News | 25.07.2019

Roche, the Basel-based pharmaceutical group, presented its half-year results this morning. The...